Evaluation of Dual Antiplatelet Therapy of Aspirin and Clopidogrel versus Aspirin and Cilostazol in patients with Acute Ischemic Stroke
Mira Mansour Salama;
Abstract
The growing problem of stroke has been highlighted by new data
suggesting that this condition is now the second leading cause of death
worldwide (after heart disease) and is projected to be the leading cause of
death by 2030. Stroke also is a leading ca
suggesting that this condition is now the second leading cause of death
worldwide (after heart disease) and is projected to be the leading cause of
death by 2030. Stroke also is a leading ca
Other data
| Title | Evaluation of Dual Antiplatelet Therapy of Aspirin and Clopidogrel versus Aspirin and Cilostazol in patients with Acute Ischemic Stroke | Other Titles | تقییم علاج مضادات الصفائح المزدوج بالأسبرین و الكلوبیدوجریل بالمقارنة بالأسبرین و السیلوستازول فى مرضى السكتة الدماغیة الحادة | Authors | Mira Mansour Salama | Keywords | Evaluation of Dual Antiplatelet Therapy of Aspirin and Clopidogrel versus Aspirin and Cilostazol in patients with Acute Ischemic Stroke | Issue Date | 2012 | Description | The growing problem of stroke has been highlighted by new data suggesting that this condition is now the second leading cause of death worldwide (after heart disease) and is projected to be the leading cause of death by 2030. Stroke also is a leading ca |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.